Company intelligence / Profile preview

TavTech

Ownership: Private
Development stage: Commercial

Overview

TavTech’s proprietary jet pressure energy technology has been in commercial use for over two decades. The company’s devices are used globally for non-invasive aesthetic treatments and wound care. Clinical results highlight effective transdermal delivery of nutrients/solutions with high patient comfort and minimal downtime[2][6].

Therapeutic areas: Dermatology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Partnerships

Collaborates with medical practitioners and scientific institutes; no major pharma/biotech partnerships publicly listed[6]

Beyond the preview

Go deeper on TavTech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TavTech.

Explore the full profile